The common stock of Regencell Bioscience Holdings Limited trades on the Nasdaq exchange under the ticker symbol RGC, with recent market valuations resting around the $5.54 per share range. Because equity prices fluctuate continuously throughout active trading sessions based on daily trading volumes, investor sentiment, and market liquidity, exact quotes change constantly. As a micro-cap clinical-stage biotechnology enterprise that lacks steady commercial product revenue, the equity has historically experienced extreme price volatility, wide trading spreads, and sharp swings relative to its multi-week and 52-week trading bounds. Market participants tracking the stock must consult live financial platforms right before executing trades to obtain precise, real-time pricing data.